Company Analysis

Precigen, Inc. (PGEN)

Nasdaq: PGEN · Pharmaceutical Preparations · Germantown, MD · filing with the SEC since 2006
Grade3.8
◀ Past 3.2● Present 4.0▶ Future 4.0
1 est.

Who runs Precigen, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Sabzevari Helen
President and CEO. First filing Dec 2017, latest Aug 25, 2026, 26 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
31 people on the record since 2013
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Thomasian Harry Jr.Chief Financial OfficerOct 2021Sep 24, 20264 · $1.9M
Sabzevari HelenPresident and CEODec 2017Aug 25, 20262 · $2.6M
Shah Rutul RChief Operating OfficerOct 2022Aug 25, 20266 · $1.3M
Lehr Donald P.Chief Legal OfficerAug 2013Aug 25, 20261 · $100,000
Tennant PhilChief Commercial OfficerJul 2024Aug 25, 20262 · $700,000
Kirk Randal JExecutive ChairmanAug 2013Mar 31, 202626 · $42.2M
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Kindler Jeffrey BdirectorAug 2013Aug 28, 20263 · $2.6M
Agee Nancy HdirectorJul 2024Aug 25, 2026none
Alvarez Cesar LdirectorAug 2013Mar 16, 2026none
Frank StevendirectorAug 2013Mar 16, 2026none
Gupta Vinita DdirectorApr 2017Mar 16, 2026none
Hassan FreddirectorJul 2016Mar 16, 2026none
Turley James SdirectorApr 2014Mar 16, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PGEN · research, not advice